- Home » News and Events
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany
Jul 16, 2024
Catalent today announced it has completed expansion of its clinical supply facility in Schorndorf, Germany.
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
May 8, 2024
Catalent will provide process development and cGMP manufacturing of Siren Biotechnology’s AAV vector-based therapeutic candidates for use in clinical trials.
Catalent Publishes Fifth Annual Corporate Responsibility Report
Mar 7, 2024
The 2023 Corporate Responsibility Report highlights progress across every pillar of Catalent’s corporate responsibility strategy – People, Environment, and Community.
Novo Holdings to Acquire Catalent
Feb 5, 2024
Catalent and Novo Holdings have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.
Catalent Announces Addition of Potent Capsule Filling Capabilities for Inhaled Dry Powders at its Boston, MA USA Facility
Feb 2, 2024
These upgrades, including the addition of capacity for both development and commercial spray drying, now position Catalent as the CDMO with the largest GMP capacity for capsule spray-dried and carrier-based inhaled powders.
Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
Jan 25, 2024
The company also committed to engaging with its suppliers such that 70% of their emissions will have reduction goals aligned with science-based targets by the end of fiscal 2028.
Catalent Appoints David McErlane as Biologics Segment Leader
Sep 18, 2023
Mr. McErlane will lead all of Catalent’s Biologics businesses and global service offerings – including development, drug substance manufacturing, drug product fill-and-finish, cell and gene therapy, and analytical services.
Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resources Officer
Aug 1, 2023
She will be responsible for leading Catalent’s global human resources strategy, including talent acquisition, leadership development, diversity and inclusion, compensation and benefits, HR operations and technology, and performance management.
Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer
Jun 20, 2023
Mr. Masanovich will have responsibility for all aspects of Catalent’s global financial operations, including financial planning and analysis, controllership, public reporting and investor relations, capital markets activities, bill payment and collection, tax, and treasury.
9th Annual CAR-TCR Summit
Date: September 17-20, 2024
NLSDays 2024
Date: September 18-19, 2024
Bio Process International East
Date: September 23-26, 2024
Webinar: Boosting Phase 1 Success: A Dedicated Scientific Partner, Accelerated Timelines & Minimal API
Date: September 24, 2024
Webinar: Optimizing Clinical Supply Flexibility with Demand-Led Strategies
Date: September 25, 2024
9th Bioproduction Congress
Date: September 25-26, 2024
SoCalBio 26th Annual Conference
Date: September 25-26, 2024
4th iPSC Drug Development & Manufacturing Summit 2024
Date: October 1-3, 2024
Cell & Gene Meeting on the Mesa
Date: October 7-9, 2024
Clinical Outsourcing Group (COG) Bay Area
Date: October 8-9, 2024
CPHI Milan
Date: October 8-10, 2024
Webinar: Oral Lipid-Based Formulations: Unlocking Value in Early-Stage Pharmaceutical Development
Date: October 16, 2024
Formulation & Delivery US 2024
Date: October 16-17, 2024
American Association of Pharmaceutical Scientists Conference 2024 PharmSci 360
Date: October 21-23, 2024
SupplySide West 2024
Date: October 30-31, 2024
Bio Europe Fall
Date: November 4-6, 2024
World ADC San Diego
Date: November 4-7, 2024
PEGS Europe
Date: November 5-7, 2024